Daklinza

Active Ingredient(s): Daclatasvir
FDA Approved: * July 24, 2015
Pharm Company: * BRISTOL MYERS SQUIBB
Category: Hepatitis

Daclatasvir, sold under the brand name Daklinza, is an antiviral medication used in combination with other medications to treat hepatitis C (HCV).[3] The other medications used in combination include sofosbuvir, ribavirin, and interferon, vary depending on the virus type and whether the person has cirrhosis.[1] It is taken by mouth.[3] Common side effects when used with sofusbivir and daclatasvir include headache, feeling tired, and nausea.&... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Daklinza 90 mg Oral Tablet
NDC: 0003-0011
Labeler:
E.r. Squibb & Sons, L.L.C.
Daklinza 30 mg Oral Tablet
NDC: 0003-0213
Labeler:
E.r. Squibb & Sons, L.L.C.
Daklinza 60 mg Oral Tablet
NDC: 0003-0215
Labeler:
E.r. Squibb & Sons, L.L.C.